HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Length-dependent pathogenic effects of nickel nanowires in the lungs and the peritoneal cavity.

Abstract
The use of fibre-shaped nanomaterials in commercial applications has met with concern that they could cause health effects similar to those seen with pathogenic fibres such as certain forms of asbestos. Of the attributes which form the fibre pathogenicity paradigm, fibre length is thought to be a critical factor in determining fibre toxicity. We have previously shown that carbon nanotubes display such length-dependent pathogenicity but it remains unclear if other forms of fibrous nanomaterials conform to the fibre pathogenicity paradigm. As such, our aim is to determine the generality of this hypothesis by asking whether a radically different form of fibrous nanomaterial, nickel nanowires, show length-dependent pathogenicity. Our results indicate that nickel nanowires synthesised to be predominantly long (>20 μm) show the ability to elicit strong inflammation in the mouse peritoneal model in a dose-dependent manner; inflammation or fibrosis was not seen with the short (<5 μm) nanowires. This length-dependent response was also seen after lung aspiration and within a macrophage in vitro model adding further weight to the contention that fibre length is an important driver of hazard potential. This may have important implications when considering the hazard posed by fibrous nanomaterials and their regulation in workplaces.
AuthorsCraig A Poland, Fiona Byrne, Wan-Seob Cho, Adriele Prina-Mello, Fiona A Murphy, Gemma Louise Davies, J M D Coey, Yurii Gounko, Rodger Duffin, Yuri Volkov, Ken Donaldson
JournalNanotoxicology (Nanotoxicology) Vol. 6 Pg. 899-911 (Dec 2012) ISSN: 1743-5404 [Electronic] England
PMID22023084 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nickel
Topics
  • Animals
  • Female
  • Lung (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Nanowires (toxicity)
  • Nickel (chemistry)
  • Peritoneal Cavity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: